iRECIST Time-Point Response (Immunotherapy Trials)
iRECIST Time-Point Response (Immunotherapy Trials) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the iRECIST Time-Point Response (Immunotherapy Trials) → Runs in your browser. No signup, no tracking.
What this is
iRECIST Time-Point Response (Immunotherapy Trials) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. iRECIST Time-Point Response (Immunotherapy Trials) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
Seymour L, Bogaerts J, Perrone A, et al. iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol. 2017;18(3):e143-e152. Read the source ↗
Worked example: iPR, after a prior iUPD.
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.